1980
DOI: 10.1021/ja00541a073
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis of the pyrimidine moiety of bleomycin

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
14
0

Year Published

1984
1984
2018
2018

Publication Types

Select...
6
3
1

Relationship

0
10

Authors

Journals

citations
Cited by 46 publications
(14 citation statements)
references
References 1 publication
0
14
0
Order By: Relevance
“…Pyrimidoblamic acid is ak ey subunit of the anticancer drug bleomycin A 2 .I ts modification would enable an improvement in or the simplification of bleomycina nalogues. Various total synthesis methods have been examined by Umezawa, [96] Hecht, [97] and Boger, [98] but there is often difficulty in controlling the stereochemistry of the tertiary carbon atom of the benzylic pyrimidine moiety Duerfeldt and Boger generate the pyrimidine core from an iEDDA reaction betweenas ubstituted electron-deficient triazine such as 78 ( Figure 25) and an amidine such as 79. [99] All the necessary stereochemistry is introduced before the cycloaddition.T his method also enables the late-stage functionalization of pyrimidoblamic acid, which allows analogues to be easily synthesized.…”
Section: Pyrimidoblamic Acidmentioning
confidence: 99%
“…Pyrimidoblamic acid is ak ey subunit of the anticancer drug bleomycin A 2 .I ts modification would enable an improvement in or the simplification of bleomycina nalogues. Various total synthesis methods have been examined by Umezawa, [96] Hecht, [97] and Boger, [98] but there is often difficulty in controlling the stereochemistry of the tertiary carbon atom of the benzylic pyrimidine moiety Duerfeldt and Boger generate the pyrimidine core from an iEDDA reaction betweenas ubstituted electron-deficient triazine such as 78 ( Figure 25) and an amidine such as 79. [99] All the necessary stereochemistry is introduced before the cycloaddition.T his method also enables the late-stage functionalization of pyrimidoblamic acid, which allows analogues to be easily synthesized.…”
Section: Pyrimidoblamic Acidmentioning
confidence: 99%
“…Bleomycins (BLMs) are the iron-based natural anti-tumour agents which show oxidative damage of DNA in cancer cells forming cytotoxic hydroxyl radicals. 27,28 Iron complexes with the metal in its +3 oxidation state are prone to reduction inside the cells by cellular reducing agents like glutathione (GSH). Iron(III) complexes having azide ligand are known to show significant DNA photocleavage activity.…”
Section: Introductionmentioning
confidence: 99%
“…Iron is no doubt the preferred choice among the transition metals for its well known bio-essentiality and low dark toxicity. The interest in the chemistry of iron-based antitumor agents emerges from the chemotherapeutic activity of bleomycins (BLMs) that are iron containing naturally occurring drugs showing an oxidative damage of DNA forming cytotoxic hydroxyl radicals [27,28]. The complex can be designed such that its dark toxicity will remain nominal but suitable photosensitizers should be ligated to the metal to ensure the efficient PDT activity.…”
Section: Introductionmentioning
confidence: 99%